^
BIOMARKER:

KRAS G12C

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
KRAS G12C
Non Small Cell Lung Cancer
sotorasib
Sensitive
:
A1
ESMO 2022 - 3 weeks - (New B)
KRAS G12C
Colorectal Cancer
MRTX849
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Colorectal Cancer
RG6330
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Solid Tumor
RG6330
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Colorectal Cancer
cetuximab + MRTX849
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Colorectal Cancer
panitumumab + sotorasib
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Colorectal Cancer
bevacizumab
Resistant
:
C3
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Non Small Cell Lung Cancer
nivolumab + rigosertib
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
KRAS G12C
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
B
KRAS G12C
Non Small Cell Lung Cancer
MRTX849
Sensitive
:
B
KRAS G12C
Lung Non-Squamous Non-Small Cell Cancer
Immunotherapy
Sensitive
:
B
KRAS G12C
Non Small Cell Lung Cancer
abemaciclib
Sensitive
:
B
KRAS G12C
Non Small Cell Lung Cancer
pembrolizumab
Sensitive
:
B
KRAS G12C
Colorectal Cancer
cetuximab
Resistant
:
B
KRAS G12C
Colorectal Cancer
panitumumab
Resistant
:
B
KRAS G12C
Ampulla of Vater Carcinoma
sotorasib
Sensitive
:
C1
KRAS G12C
Pancreatic Cancer
sotorasib
Sensitive
:
C1
KRAS G12C
Melanoma
sotorasib
Sensitive
:
C1
KRAS G12C
Endometrial Cancer
sotorasib
Sensitive
:
C1
KRAS G12C
Colorectal Cancer
sotorasib
Sensitive
:
C1
KRAS G12C
Gastrointestinal Cancer
sotorasib
Sensitive
:
C1
KRAS G12C
Solid Tumor
D-1553
Sensitive
:
C2
KRAS G12C
Lung Cancer
D-1553
Sensitive
:
C2
KRAS G12C
Colorectal Cancer
MEK inhibitor + sotorasib
Sensitive
:
C2
KRAS G12C
Non Small Cell Lung Cancer
SAR442720
Sensitive
:
C2
KRAS G12C
Gastrointestinal Cancer
MRTX849
Sensitive
:
C2
KRAS G12C
Solid Tumor
GFH925
Sensitive
:
C2
KRAS G12C
Solid Tumor
JAB-21822
Sensitive
:
C2
KRAS G12C
Non Small Cell Lung Cancer
D-1553
Sensitive
:
C2
KRAS G12C
Non Small Cell Lung Cancer
RG6330
Sensitive
:
C2
KRAS G12C
Non Small Cell Lung Cancer
trametinib
Sensitive
:
C2
KRAS G12C
Non Small Cell Lung Cancer
selumetinib
Sensitive
:
C3
KRAS G12C
Cholangiocarcinoma
MRTX849
Sensitive
:
C3
KRAS G12C
Ovarian Cancer
MRTX849
Sensitive
:
C3
KRAS G12C
Pancreatic Cancer
MRTX849
Sensitive
:
C3
KRAS G12C
Endometrial Cancer
MRTX849
Sensitive
:
C3
KRAS G12C
Non Small Cell Lung Cancer
PD-L1 inhibitor
Sensitive
:
C3
KRAS G12C
Solid Tumor
IN10018 + MRTX1257
Sensitive
:
C3
KRAS G12C
Hepatocellular Cancer
sorafenib + BAY86-9766
Sensitive
:
C3
KRAS G12C
Non Small Cell Lung Cancer
erlotinib
Resistant
:
C3